UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENTUnsecured Convertible Note Purchase Agreement • February 2nd, 2022 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 2nd, 2022 Company Industry JurisdictionTHIS UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of ______________ (the “Effective Date”), between Oncotelic Therapeutics, Inc., a Delaware corporation (the “Company”), on the one hand, and Golden Mountain Partners, LLC, a California Limited Liability Company (the “Purchaser”), on the other hand.
UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENTUnsecured Convertible Note Purchase Agreement • October 28th, 2021 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledOctober 28th, 2021 Company Industry JurisdictionTHIS UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of October 25, 2021 (the “Effective Date”), between Oncotelic Therapeutics, Inc., a Delaware corporation (the “Company”), on the one hand, and Golden Mountain Partners, LLC, a California Limited Liability Company (the “Purchaser”), on the other hand.
UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENTUnsecured Convertible Note Purchase Agreement • September 27th, 2021 • Oncotelic Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionTHIS UNSECURED CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of September 21, 2021 (the “Effective Date”), between Oncotelic Therapeutics, Inc., a Delaware corporation (the “Company”), on the one hand, and Golden Mountain Partners, LLC, a California Limited Liability Company (the “Purchaser”), on the other hand.